Cargando…
Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions
The enigma of why some premalignant or pre-invasive breast lesions transform and progress while others do not remains poorly understood. Currently, no radiologic or molecular biomarkers exist in the clinic that can successfully risk-stratify high-risk lesions for malignant transformation or tumor pr...
Autores principales: | Wright, Nikita, Gong, Zhihong, Kittles, Rick, Natarajan, Rama, Jovanovic-Talisman, Tijana, Rida, Padmashree, LaBarge, Mark, Seewaldt, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708236/ https://www.ncbi.nlm.nih.gov/pubmed/34945833 http://dx.doi.org/10.3390/jpm11121361 |
Ejemplares similares
-
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention
por: Jinna, Nikita, et al.
Publicado: (2022) -
Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers
por: Jinna, Nikita, et al.
Publicado: (2023) -
Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
por: Jinna, Nikita, et al.
Publicado: (2022) -
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations
por: Jinna, Nikita, et al.
Publicado: (2022) -
Discovery of
2-(3-Benzamidopropanamido)thiazole-5-carboxylate
Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular
Target Engagement Probes
por: Saint-Dizier, François, et al.
Publicado: (2023)